Review of economic analyses of treatment for non-small-cell lung cancer (NSCLC).
Alain VergnenegreChristos ChouaidPublished in: Expert review of pharmacoeconomics & outcomes research (2018)
Drug costs are one of the major challenges of LC management. The multiplication of medical-economic analyses will assure better access to the marketing of these new and expensive therapeutic agents, but also to the selection of the best management strategy for these cancers.